Sarfez Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSarfez Pharmaceuticals

Sarfez Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Soaanz	Torsemide	2021-06-14	2033	Heart failure , Hypertension , Chronic kidney failure , Liver cirrhosis , Nephrotic syndrome , Edema , Ascites , Pulmonary edema

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

food-drug interactions

,

chronic renal insufficiency

,

kidney diseases

,

,

body weight changes

,

overactive urinary bladder

,

urinary incontinence

,

healthy volunteers/patients

,

,

,

,

left ventricular dysfunction

,

ventricular dysfunction

,

Histone-arginine methyltransferase carm1

,

squamous cell carcinoma of head and neck

,

healthy volunteers/patients

,

squamous cell carcinoma

,

triple negative breast neoplasms

,

,

lymphoid leukemia

,

head and neck neoplasms

,

colorectal neoplasms

,

,

parkinson disease

,

myeloid leukemia acute

,

myeloid leukemia

,

squamous cell neoplasms

,

,

non-hodgkin lymphoma

,

b-cell chronic lymphocytic leukemia

,

acute kidney injury

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

liver cirrhosis

,

,

,

chronic hepatitis c

,

,

chronic hepatitis

,

,

,

vascular surgical procedures

,

wounds and injuries

,

b-cell lymphoma marginal zone

,

pancreatic neoplasms

,

esophageal neoplasms

,

,

urologic neoplasms

,

transitional cell carcinoma

,

,

non-small-cell lung carcinoma

,

multiple myeloma

,

plasma cell neoplasms

,

hepatocellular carcinoma

,

liver neoplasms

,

,

myelodysplastic syndromes

,

,

,

,

takayasu arteritis

,

aortic arch syndromes

,

ovarian neoplasms

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

hypersensitivity

,

,

healthy volunteers/patients

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

triple negative breast neoplasms

,

head and neck neoplasms

,

parkinson disease

,

,

myeloid leukemia acute

,

myeloid leukemia

,

non-hodgkin lymphoma

,

,

acute kidney injury

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

liver cirrhosis

,

,

,

chronic hepatitis c

,

,

chronic hepatitis

,

,

,

vascular surgical procedures

,

wounds and injuries

,

b-cell chronic lymphocytic leukemia

,

b-cell lymphoma marginal zone

,

pancreatic neoplasms

,

esophageal neoplasms

,

,

urologic neoplasms

,

transitional cell carcinoma

,

,

multiple myeloma

,

plasma cell neoplasms

,

non-small-cell lung carcinoma

,

myelodysplastic syndromes

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

,

takayasu arteritis

,

aortic arch syndromes

,

ovarian neoplasms

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

hypersensitivity

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use